
Advent Life Sciences
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Advent Life Sciences is a venture capital firm investing in life sciences businesses.
Investor Profile
Advent Life Sciences has made 64 investments, with 5 in the past 12 months and 34% as lead.
Stage Focus
- Series A (27%)
- Series Unknown (23%)
- Series B (20%)
- Series C (11%)
- Seed (8%)
- Private Equity (3%)
- Series E (3%)
- Convertible Note (3%)
- Series D (2%)
Country Focus
- United States (53%)
- United Kingdom (34%)
- France (5%)
- Ireland (2%)
- Norway (2%)
- Switzerland (2%)
- Finland (2%)
- Spain (2%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Pharmaceutical
- Therapeutics
- Medical Device
- Biopharma
- Life Science
- Manufacturing
- Information Technology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.